BC Cancer Agency

Details BC Cancer Agency BC Cancer Agency

www.bccrc.ca

British Columbia

Vancouver

Vancouver

Corporation

active

Operating name: Investigational Drug Program, BCCRC



The Investigational Drug Program is a comprehensive unit offering a full range of services in three basic areas: i) preclinical drug assessment, ii) formal investigational drug development and iii) clinical trials conducted at the BCCA. IDP staff have expertise with a variety of drug classes, including conventional small molecule drugs and immunotherapy through to gene therapy approaches. Services offered include cell culture and characterisation, drug cytotoxicity testing, in vivo tumour model development, efficacy studies and GLP toxicology, analytical development, validation and stability studies, and finally, aseptic parenteral manufacturing for GLP toxicology or Phase I/II clinical trials.
Country of Ownership: Canada
Exporting: No
Primary Industry (NAICS): 541380 - Testing Laboratories
Alternate Industries (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer

Services:
Pharmaceutical drug development

Affiliated with

Also associated with

No associations

Rating

BC Cancer Agency does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with BC Cancer Agency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BC Cancer Agency will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-COD-O-16482